Evidence map›Paper›PMID 21214913›Full record

ArticleBMC public health2011

Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Patrick K Moonan, Teresa N Quitugua, Janice M Pogoda, Gary Woo, Gerry Drewyer, Behzad Sahbazian, Denise Dunbar, Kenneth C Jost, Charles Wallace, Stephen E Weis

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC public health, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04134689 (DOT Selfie), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04134689 nacompletednot on this mapstarted 2020, after this paper: background citation

DOT Selfie: A Mobile Health Intervention With Transfer of Social Bundle Incentives to Increase Treatment Adherence in Tuberculosis Patients in Uganda: A Randomized Control Trial.

TypeinterventionalSponsorUniversity of GeorgiaRan2020 to 2023Enrolled144ConditionsTuberculosisArmsDOT Selfie Intervention, In-person DOT
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Directly observed therapy for treating tuberculosis.The Cochrane database of systematic reviews · 2015
    Pooled it
  4. Trial
  5. Effect of Short Message Service on Management of Pulmonary Tuberculosis Patients in Anhui Province, China: A Prospective, Randomized, Controlled Study.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Trial
  6. Article
  7. Perceptions and experiences of directly observed treatment in tuberculosis: insights from a mixed-methods cross-sectional study.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2025
    Article
  8. Article
  9. Standards for clinical trials for treating TB.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Patient Compliance: Fact or Fiction?Innovations in pharmacy · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Patrick K MoonanUniversity of North Texas Health Science Center at Fort Worth, Department of Medicine, USA.
Teresa N Quitugua
Janice M Pogoda
Gary Woo
Gerry Drewyer
Behzad Sahbazian
Denise Dunbar
Kenneth C Jost
Charles Wallace
Stephen E Weis
Texas Department of State Health Services · USUniversity of North Texas · USDallas County · USTarrant County College · USThe University of Texas Health Science Center at San Antonio · USVentura College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDirectly observed therapy (DOT) is a widely recommended and promoted strategy to manage tuberculosis (TB), however, there is still disagreement about the role of DOT in TB control and the impact it has on reducing the acquisition and transmission of drug resistant TB. This study compares the portion of drug resistant genotype clusters, representing recent transmission, within and between communities implementing programs differing only in their directly observed therapy (DOT) practices.

methodsGenotype clusters were defined as 2 or more patient members with matching IS6110 restriction fragment length polymorphism (RFLP) and spoligotype patterns from all culture-positive tuberculosis cases diagnosed between January 1, 1995 and December 31, 2001. Logistic regression was used to compute maximum-likelihood estimates of odds ratios (ORs) and 95% confidence intervals (CIs) comparing cluster members with and without drug resistant isolates. In the universal DOT county, all patients received doses under direct observation of health department staff; whereas in selective DOT county, the majority of received patients doses under direct observation of health department staff, while some were able to self-administer doses.

resultsIsolates from 1,706 persons collected during 1,721 episodes of tuberculosis were genotyped. Cluster members from the selective DOT county were more than twice as likely than cluster members from the universal DOT county to have at least one isolate resistant to isoniazid, rifampin, and/or ethambutol (OR = 2.3, 95% CI: 1.7, 3.1). Selective DOT county isolates were nearly 5 times more likely than universal DOT county isolates to belong to clusters with at least 2 resistant isolates having identical resistance patterns (OR = 4.7, 95% CI: 2.9, 7.6).

conclusionsUniversal DOT for tuberculosis is associated with a decrease in the acquisition and transmission of resistant tuberculosis.

Indexed as

Directly Observed TherapyGenotypeAdultAgedChildChild, PreschoolCluster AnalysisDrug ResistanceFemaleHumansLogistic ModelsMaleMicrobial Sensitivity TestsMiddle AgedMolecular EpidemiologyMycobacterium tuberculosis

Identifiers

PMID21214913
PMCPMC3032680
OpenAlexW1987148945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.